We have shown that disruption of TCF/β-catenin binding with PKF118-310 produces <i>in vitro</i> antitumor activity in a panel of prevalent representative STS cell lines and primary cultures.
Nuclear beta-catenin staining in soft tissue sarcomas (STSs) has been shown to correlate with tumor progression as assessed by proliferative activity or poor prognosis.